Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

ClinicalTrials.gov ID: NCT01481077

Public ClinicalTrials.gov record NCT01481077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 9:09 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PPL GLAU 13: A Randomized Phase 2 Study of the Effect of Plug Placement on Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effect of plug placement on the efficacy, safety and duration of effect of the L-PPDS (latanoprost punctal plug delivery system).

Study identification

NCT ID
NCT01481077
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mati Therapeutics Inc.
Industry
Enrollment
77 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2011 (Type not available)
Primary completion
Sep 2012 (Actual)
Completion
Sep 2012 (Actual)
Last update posted
Sep 26, 2013

2011 – 2012

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
11
Facility City State ZIP Site status
Vold Vision Springdale Arkansas 72762 —
Glaucoma Consultants of Colorado, PC Denver Colorado 80134 —
Danbury Eye Physicians & Surgeons Danbury Connecticut 06810 —
Ophthalmology Consultants Inc. Des Peres Missouri 63131 —
Ophthalmology Associates St Louis Missouri 63131 —
Comprehensive Eye Care, Ltd Washington Missouri 63090 —
Las Vegas Physicians Research Group Henderson Nevada 89052 —
Abrams Eye Institute Las Vegas Nevada 89148 —
Philadelphia Eye Associates Philadelphia Pennsylvania 19148 —
University Eye Surgeons Maryville Tennessee 37803 —
Total Eye Care, P.A. Memphis Tennessee 38119 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01481077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2013 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01481077 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →